Operationalizing Subcutaneous Checkpoint Inhibitors in Practice. Implementing subcutaneous checkpoint inhibitors requires ...

Balazs Halmos, MD, discussed the potential impact of subcutaneous amivantamab for patients with EGFR -mutated NSCLC. Halmos ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

Within hours of the murder of conservative podcaster and activist Charlie Kirk—and in the absence of a suspect—high-profile figures on the right, from vice president JD Vance to deputy White House ...

The Trump administration is offering nine prominent U.S. universities preferential access to federal funds if they pledge to take a series of steps that align with the Republican administration’s ...

In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...

The Trump administration is pulling a federal watchdog off the beat in Washington, effective Wednesday, stripping funding from the Council of Inspectors General. Removing the council's funding will ...

It’s the end of the road for those who took the “Fork in the Road.” Regardless of what happens if and when the government shuts down, Tuesday is the last day on the payroll for more than 100,000 ...

Environmental enforcement has hit historic lows, as the Trump administration has brought fewer lawsuits against companies for environmental violations in its first six months than any other ...

This is read by an automated voice. Please report any issues or inconsistencies here. California, 10 other states and D.C. sued, arguing the cuts illegally cost them hundreds of millions in emergency ...

President Donald Trump's efforts to be the "law and order" president could soon be ruled illegal. Oregon has filed suit against the Trump administration and is seeking a temporary restraining order to ...

Larimar Therapeutics Inc. (NASDAQ: LRMR) is trading lower on Monday after the company released data from the ongoing long-term open-label (OL) study evaluating daily subcutaneous 25 mg and 50 mg ...